Are Serum Levels of F2-Isoprostane and Oxidized-LDL Related to Vitamin D Status in Type 2 Diabetic Patients? A Case-Control Study.

Mohammad Hassan Javanbakht, Hamed Mohammady, Koorosh Fooladsaz, Maryam Razzaghi, Mahnaz Zarei, Mahmoud Djalali
Author Information
  1. Mohammad Hassan Javanbakht: Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
  2. Hamed Mohammady: Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
  3. Koorosh Fooladsaz: Department of Clinical Biochemistry, Zanjan University of Medical Sciences, Zanjan, Iran.
  4. Maryam Razzaghi: Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
  5. Mahnaz Zarei: Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
  6. Mahmoud Djalali: Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

BACKGROUND: Considerable evidence suggests that oxidative stress affects diabetes mellitus (DM) and contributes to its complications. Vitamin D has been shown to possess antioxidant properties. The aim of this study was to determine the association between serum levels of calcifediol (25-OH-D), an indicator of vitamin D status, and lipid profiles with oxidative stress in patients with type 2 diabetes mellitus (T2DM).
METHODS: In this case-control study, 57 T2DM patients with low vitamin D status (< 30 ng/mL) and 48 T2DM patients with normal vitamin D status (> 30 ng/mL) were enrolled. Fasting concentrations of 25-OH-D, calcium, phosphorus, parathyroid hormone (PTH), lipid profiles, fasting blood sugar (FBS), glycosylated hemoglobin (HbA1c), F2-isoprostane, and oxidized-low-density lipoprotein (ox-LDL) were measured.
RESULTS: The mean fasting serum concentrations of 25-OH-D, calcium, and phosphorus in patients with low vitamin D status were significantly lower than in controls (p < 0.001). The mean concentrations of ox-LDL, F2-isoprostane, total cholesterol, and LDL were significantly higher in patients with low vitamin D status than in controls. There was a negative correlation between vitamin D levels and F2-isoprostane (r = 0.647and P = 0.0001), LDL (r = -0.218 and P = 0.030), and ox-LDL (r = -0.637 and P = 0.0001).
CONCLUSION: The results of present study indicated that serum concentrations of 25-OH-D were inversely correlated with F2-isoprostane, LDL, and ox-LDL. Therefore, vitamin D may have a beneficial effect on the control of lipid profiles and oxidative stress in T2DM patients.

Keywords

References

  1. Cardiovasc Diabetol. 2005 Apr 29;4:5 [PMID: 15862133]
  2. Clin Chem Lab Med. 2003 Sep;41(9):1199-212 [PMID: 14598870]
  3. Diabetes Care. 2007 Oct;30(10):2569-70 [PMID: 17626891]
  4. J Physiol Biochem. 2008 Sep;64(3):231-9 [PMID: 19244937]
  5. Bone. 2006 Jun;38(6):888-92 [PMID: 16464653]
  6. Nat Rev Cancer. 2007 Sep;7(9):684-700 [PMID: 17721433]
  7. Diabetes. 1999 Jan;48(1):1-9 [PMID: 9892215]
  8. Am J Med Genet. 2002 May 30;115(1):18-29 [PMID: 12116173]
  9. J Nutr Sci Vitaminol (Tokyo). 2009 Jun;55(3):215-22 [PMID: 19602829]
  10. Rheumatology (Oxford). 2008 Jun;47(6):920-3 [PMID: 18411213]
  11. Exp Biol Med (Maywood). 2004 Dec;229(11):1136-42 [PMID: 15564440]
  12. Curr Rheumatol Rep. 2008 Aug;10(4):273-80 [PMID: 18662506]
  13. Int J Epidemiol. 2013 Oct;42(5):1215-22 [PMID: 24159065]
  14. Diabetes Care. 2004 May;27(5):1047-53 [PMID: 15111519]
  15. Prog Lipid Res. 2011 Oct;50(4):303-12 [PMID: 21640757]
  16. Indian J Med Sci. 2013 Jan-Feb;67(1-2):29-37 [PMID: 24178339]
  17. Arthritis Rheum. 2007 Jul;56(7):2143-9 [PMID: 17599737]
  18. Endocrinol Metab Clin North Am. 2010 Jun;39(2):419-46, table of contents [PMID: 20511061]
  19. Klin Wochenschr. 1991 Dec 15;69(21-23):965-8 [PMID: 1798292]
  20. Osteoporos Int. 2009 Mar;20(3):427-33 [PMID: 18600287]
  21. Am J Hypertens. 2007 Jul;20(7):713-9 [PMID: 17586404]
  22. Diabetes Care. 2004 Dec;27(12):2813-8 [PMID: 15562190]
  23. J Am Coll Nutr. 2011 Jun;30(3):167-70 [PMID: 21896873]
  24. J Diabetes Metab Disord. 2014 Jan 07;13(1):7 [PMID: 24398023]
  25. Clin Exp Med. 2005 May;5(1):31-6 [PMID: 15928880]
  26. Iran J Public Health. 2014 Nov;43(11):1544-9 [PMID: 26060722]
  27. Diabet Med. 2000 Mar;17(3):171-80 [PMID: 10784220]
  28. Lancet. 2001 Nov 3;358(9292):1500-3 [PMID: 11705562]

Word Cloud

Created with Highcharts 10.0.0Dvitaminpatients=statusF2-isoprostane0stress25-OH-DT2DMconcentrationsox-LDLoxidativemellitusVitaminstudyserumlipidprofiles2lowLDLrPdiabeteslevelstype<30ng/mLcalciumphosphorusfastingmeansignificantlycontrols0001-0BACKGROUND:ConsiderableevidencesuggestsaffectsDMcontributescomplicationsshownpossessantioxidantpropertiesaimdetermineassociationcalcifediolindicatorMETHODS:case-control5748normal>enrolledFastingparathyroidhormonePTHbloodsugarFBSglycosylatedhemoglobinHbA1coxidized-low-densitylipoproteinmeasuredRESULTS:lowerp001totalcholesterolhighernegativecorrelation647and218030637CONCLUSION:resultspresentindicatedinverselycorrelatedThereforemaybeneficialeffectcontrolSerumLevelsF2-IsoprostaneOxidized-LDLRelatedStatusTypeDiabeticPatients?Case-ControlStudyDiabetesOx-LDLOxidative

Similar Articles

Cited By (1)